Biotechnology
Healthcare
Investing News
Market News
Technology
Seres Therapeutics Reports Positive Topline Results from the Pivotal Phase 3 ECOSPOR III Study
Seres Therapeutics, Inc. (NASDAQ: MCRB) stock has skyrocketed more than 350% after the a microbiome therapeutics platform company announced positive topline results from the pivotal Phase 3 ECOSPOR III study...